We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+3.19%
1 Year Est. Return
+57.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.97B
AUM Growth
-$66.4M
Cap. Flow
-$138M
Cap. Flow %
-6.98%
Top 10 Hldgs %
33.39%
Holding
411
New
48
Increased
72
Reduced
134
Closed
43

Top Buys

Rank Stock Value
1
EHC icon
Encompass Health
EHC
+$25M
2
HCA icon
HCA Healthcare
HCA
+$24.4M
3
IR icon
Ingersoll Rand
IR
+$11.4M
4
NKE icon
Nike
NKE
+$11.1M
5
NDSN icon
Nordson
NDSN
+$10.9M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$32.7M
2
ABBV icon
AbbVie
ABBV
+$21.4M
3
GNRC icon
Generac Holdings
GNRC
+$20.6M
4
FTNT icon
Fortinet
FTNT
+$18.7M
5
PH icon
Parker-Hannifin
PH
+$18M

Sector Composition

Rank Sector Weight
1 Technology 31.78%
2 Healthcare 14.22%
3 Consumer Discretionary 13.46%
4 Financials 12.64%
5 Industrials 10.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGTX icon
351
TG Therapeutics
TGTX
$7.52B
$4K ﹤0.01%
120
CAMP
352
DELISTED
CalAmp Corp.
CAMP
$4K ﹤0.01%
16
NVTA
353
DELISTED
Invitae Corporation
NVTA
$4K ﹤0.01%
130
ACAD icon
354
Acadia Pharmaceuticals
ACAD
$5.06B
$3K ﹤0.01%
+160
New +$3.08K
ALLK
355
DELISTED
Allakos
ALLK
$3K ﹤0.01%
30
APLS
356
DELISTED
Apellis Pharmaceuticals
APLS
$3K ﹤0.01%
80
FOLD
357
DELISTED
Amicus Therapeutics
FOLD
$3K ﹤0.01%
300
IRWD icon
358
Ironwood Pharmaceuticals
IRWD
$669M
$3K ﹤0.01%
230
PTCT icon
359
PTC Therapeutics
PTCT
$6.23B
$3K ﹤0.01%
70
XNCR icon
360
Xencor
XNCR
$1.6B
$2K ﹤0.01%
60
KRTX
361
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$2K ﹤0.01%
+20
New +$2.31K
KYNB
362
Kyntra Bio
KYNB
$28.2M
$1K ﹤0.01%
3
HRTX icon
363
Heron Therapeutics
HRTX
$63.4M
$1K ﹤0.01%
120
ALLO icon
364
Allogene Therapeutics
ALLO
$725M
-60
Closed -$2K
AMCR icon
365
Amcor
AMCR
$21.8B
-394
Closed -$23K
AMED
366
DELISTED
Amedisys
AMED
-24,815
Closed -$6.08M
AMWD
367
DELISTED
American Woodmark
AMWD
-3,753
Closed -$307K
APAM icon
368
Artisan Partners
APAM
$3B
-230
Closed -$12K
ATO icon
369
Atmos Energy
ATO
$28.4B
-82,830
Closed -$7.96M
DVN icon
370
Devon Energy
DVN
$49.9B
-320
Closed -$9K
EBS icon
371
Emergent Biosolutions
EBS
$229M
-50
Closed -$3K
EC icon
372
Ecopetrol
EC
$35.1B
-680
Closed -$10K
EQT icon
373
EQT Corp
EQT
$33.8B
-370
Closed -$8K
AGNT
374
AGNT Inc
AGNT
$715M
-260
Closed -$10K
FTI icon
375
TechnipFMC
FTI
$29.1B
-1,100
Closed -$10K

Similar funds

Smith Group Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, Smith Group Asset Management held 411 positions worth $1.97B, down 3.3% from $2.04B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Smith Group Asset Management withdrew a net $138M in Q3 2021, closing 43 positions and reducing 134 holdings. Its most notable exit was Illinois Tool Works, an estimated $17M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Smith Group Asset Management opened a new position in HCA Healthcare worth $24.2M.

  • Smith Group Asset Management's largest Q3 2021 buy was HCA Healthcare: 99,762 shares worth $24.2M.
  • Smith Group Asset Management added most to Encompass Health in Q3 2021, an estimated $25M increase.
  • Smith Group Asset Management's biggest Q3 2021 reduction was Amazon, cutting an estimated $32.7M.
  • Smith Group Asset Management fully exited Illinois Tool Works in Q3 2021, selling an estimated $17M.
  • Smith Group Asset Management's ten largest holdings make up 33% of its $1.97B portfolio in Q3 2021.
  • Smith Group Asset Management opened 48 new positions and closed 43 in Q3 2021.
  • Smith Group Asset Management's portfolio value fell 3.3% quarter-over-quarter to $1.97B.

Based on Smith Group Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.